Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 84Observational 1

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Sleep Initiation and Maintenance Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Hematologic Diseases 1Fatigue 1Fallopian Tube Neoplasms 1Depression 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 60palbociclib 37Trastuzumab 31Letrozole 26Immunohistochemistry 26Drug Therapy 24Anastrozole 24Radiotherapy 21Gene Expression Profiling 20Amplified Fragment Length Polymorphism Analysis 20Mastectomy, Segmental 19Biopsy 19Tamoxifen 18exemestane 17Interviews as Topic 17ribociclib 16Mastectomy 16Fulvestrant 16Paclitaxel 15Magnetic Resonance Spectroscopy 15Psychiatric Rehabilitation 14High-Energy Shock Waves 14Polymerase Chain Reaction 13Observation 13Microarray Analysis 13Capecitabine 13trastuzumab deruxtecan 12Neoadjuvant Therapy 12Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms × Filgrastim × Clear all
NCT02921191 2023-07-27

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Biologics & Biosimilars Collective Intelligence Consortium

Completed
57,725 enrolled
BreastThoracic

Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡